ADVANCED NSCLC

Clinical trials for ADVANCED NSCLC explained in plain language.

Never miss a new study

Get alerted when new ADVANCED NSCLC trials appear

Sign up with your email to follow new studies for ADVANCED NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Completed 1 Terminated 1

Lung cancer gene map after drug failure could guide next steps

Knowledge-focused Completed

This completed study looked at gene changes in 182 people with advanced lung cancer whose disease got worse after first-line treatment with Osimertinib. Researchers collected tissue and blood samples to understand why the drug stopped working. The goal is to use this information …

Matched conditions: ADVANCED NSCLC

Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Knowledge-focused

Last updated Jun 26, 2026 15:56 UTC

ADVANCED NSCLC

Get alerted when new ADVANCED NSCLC trials appear

Lung cancer gene map after drug failure could guide next steps